281 related articles for article (PubMed ID: 26164555)
1. Histone deacetylase 6 delays motor neuron degeneration by ameliorating the autophagic flux defect in a transgenic mouse model of amyotrophic lateral sclerosis.
Chen S; Zhang XJ; Li LX; Wang Y; Zhong RJ; Le W
Neurosci Bull; 2015 Aug; 31(4):459-68. PubMed ID: 26164555
[TBL] [Abstract][Full Text] [Related]
2. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.
Zhang X; Chen S; Song L; Tang Y; Shen Y; Jia L; Le W
Autophagy; 2014 Apr; 10(4):588-602. PubMed ID: 24441414
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles for motor neuron autophagy early and late in the SOD1
Rudnick ND; Griffey CJ; Guarnieri P; Gerbino V; Wang X; Piersaint JA; Tapia JC; Rich MM; Maniatis T
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8294-E8303. PubMed ID: 28904095
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Zhang X; Li L; Chen S; Yang D; Wang Y; Zhang X; Wang Z; Le W
Autophagy; 2011 Apr; 7(4):412-25. PubMed ID: 21193837
[TBL] [Abstract][Full Text] [Related]
5. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
6. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
7. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
9. Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS.
Taes I; Timmers M; Hersmus N; Bento-Abreu A; Van Den Bosch L; Van Damme P; Auwerx J; Robberecht W
Hum Mol Genet; 2013 May; 22(9):1783-90. PubMed ID: 23364049
[TBL] [Abstract][Full Text] [Related]
10. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
11. Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis.
Wang Q; Zhang X; Chen S; Zhang X; Zhang S; Youdium M; Le W
Neurodegener Dis; 2011; 8(5):310-21. PubMed ID: 21346313
[TBL] [Abstract][Full Text] [Related]
12. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
13. "Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.
Coughlan KS; Mitchem MR; Hogg MC; Prehn JH
Neurobiol Aging; 2015 Feb; 36(2):1140-50. PubMed ID: 25443289
[TBL] [Abstract][Full Text] [Related]
14. Roflupram alleviates autophagy defects and reduces mutant hSOD1-induced motor neuron damage in cell and mouse models of amyotrophic lateral sclerosis.
Huo D; Liang W; Wang D; Liu Q; Wang H; Wang Y; Zhang C; Cong C; Su X; Tan X; Zhang W; Han L; Zhang D; Wang M; Feng H
Neuropharmacology; 2024 Apr; 247():109812. PubMed ID: 38218579
[TBL] [Abstract][Full Text] [Related]
15. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
[TBL] [Abstract][Full Text] [Related]
16. HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation.
Gal J; Chen J; Barnett KR; Yang L; Brumley E; Zhu H
J Biol Chem; 2013 May; 288(21):15035-45. PubMed ID: 23580651
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
19. Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice.
Staats KA; Van Helleputte L; Jones AR; Bento-Abreu A; Van Hoecke A; Shatunov A; Simpson CL; Lemmens R; Jaspers T; Fukami K; Nakamura Y; Brown RH; Van Damme P; Liston A; Robberecht W; Al-Chalabi A; Van Den Bosch L
Neurobiol Dis; 2013 Dec; 60():11-7. PubMed ID: 23969236
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
